• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 20
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 20
  • Directory
  • Microsites
  • Events
    • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Next-Gen Lab Services
    Biopharma Manufacturing Facility Construction
    Reviving Local Production of Antibiotic Powders
    Understanding the Pharma Manufacturer’s Dilemma
    Pharma Development & Manufacturing Trends
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Alexis Peyroles Departs OSE Immunotherapeutics as CEO
    CARsgen Therapeutics Appoints President of U.S. Ops
    Hikma Acquires Teligent Sterile Injectable Assets for $45.75M
    Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement for COVID Oral Antivirals
    Neurimmune, Ono Expand Neurodegenerative Discovery Collaboration
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Leveraging the Blow-Fill-Seal Process and Cold BFS Technology for Biologics
    Pharma Outlook 2022
    Forge Biologics to Expand Manufacturing Facility
    Procaps Group Expands Global CDMO Business
    Eurofins CDMO Expands Spray Drying Capabilities
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Procaps Group Expands Global CDMO Business
    Catalent Increases Specialized Packaging Capabilities
    UPS Surpasses One Billion COVID-19 Vaccine Delivery Mark
    Avantor Opens Single-Use Logistics Hub
    Alcami Acquires Masy BioServices
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement for COVID Oral Antivirals
    Neurimmune, Ono Expand Neurodegenerative Discovery Collaboration
    Leveraging the Blow-Fill-Seal Process and Cold BFS Technology for Biologics
    Pharma Outlook 2022
    Forge Biologics to Expand Manufacturing Facility
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pharma Outlook 2022
    Ardena Expands Capacity to Satisfy Novavax COVID Vaccine Demand
    WuXi STA Passes First U.S. FDA PAI at Waigaoqiao Site
    WuXi STA, Coherent Biopharma Enter Strategic PDC Pact
    Pharmacovigilance: Improving Public Health
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Vector Partners Limited
    Baxter BioPharma Solutions
    Quotient Sciences
    Qosina
    Recro
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Vector Partners Limited
    Baxter BioPharma Solutions
    Quotient Sciences
    Qosina
    Recro
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    Trials & Filings in Brief: Oct. 30, 2013

    Acacia, Flexion, GSK KaloBios, MannKind, Merrimack, RedHill, Spectrum, Theravance

    Related CONTENT
    • Mogene
    • Solving the Pharma Talent Crunch
    • Akebia Therapeutics Names CMO
    • Selexis SA and OSE Immunotherapeutics Enter Pact
    • CROS NT Expands Medidata Pact
    Gil Roth10.30.13
    Phase II
    Acacia begins CINV trial . . . read more

    Flexion posts good OA results . . . read more

    Merrimack ovarian cancer treatment falls short . . . read more

    Spectrum completes enrollment for melphalan trial . . . read more

    Phase III
    RedHill starts H.pylori trial . . . read more

    Filings
    KaloBios gets orphan designation for CF treatment . . . read more

    FDA Accepts Afrezza Submission . . . read more

    Launches
    GSK, Theravance launch Breo Ellipta . . . read more
    Related Searches
    • contractpharma
    • Phase III
    • www.contractpharma.com
    • Phase II
    Suggested For You
    Mogene Mogene
    Solving the Pharma Talent Crunch Solving the Pharma Talent Crunch
    Akebia Therapeutics Names CMO Akebia Therapeutics Names CMO
    Selexis SA and OSE Immunotherapeutics Enter Pact Selexis SA and OSE Immunotherapeutics Enter Pact
    CROS NT Expands Medidata Pact CROS NT Expands Medidata Pact
    Worldwide Clinical Trials Appoints Clinical Ops VP Worldwide Clinical Trials Appoints Clinical Ops VP
    GSK Invests $139M to Expand Benlysta Capacity GSK Invests $139M to Expand Benlysta Capacity
    PAREXEL Appoints SVP, CFO PAREXEL Appoints SVP, CFO
    Epizyme Earns Milestone Payment from GSK Epizyme Earns Milestone Payment from GSK
    GSK Exercises Five Prime License Option GSK Exercises Five Prime License Option
    6 GlaxoSmithKline 6 GlaxoSmithKline
    Developments in Orphan Drug Exclusivity After Depomed Developments in Orphan Drug Exclusivity After Depomed
    BMS to Pay $1.25B for Promedior BMS to Pay $1.25B for Promedior
    Boyds Join Clinical Program Team to Develop Orphan Drug Boyds Join Clinical Program Team to Develop Orphan Drug
    Trials & Filings in Brief: Dec. 6, 2013 Trials & Filings in Brief: Dec. 6, 2013

    Related Breaking News

    • Biologics, Proteins, Vaccines | Breaking News | Drug Development | Industry News
      Everest Medicines, Singapore

      Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement for COVID Oral Antivirals

      Everest gains exclusive global rights to a series of 3CL protease inhibitors to treat COVID-19.
      01.17.22
    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Neurimmune, Ono Expand Neurodegenerative Discovery Collaboration

      Neurimmune, Ono Expand Neurodegenerative Discovery Collaboration

      Aims to generate and validate human-derived monoclonal antibodies against Ono's newly selected drug targets in the field of neurodegenerative diseases.
      01.17.22
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News
      Forge Biologics to Expand Manufacturing Facility

      Forge Biologics to Expand Manufacturing Facility

      Site in Columbus, OH will increase to over 200,000 square feet backed by $80mn in financing to accelerate CDMO expansion.
      01.14.22
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      Andelyn Biosciences to Offer Faster Gene Therapy Development

      Andelyn Biosciences to Offer Faster Gene Therapy Development

      FDA accepts GMP plasmid DMF and capacity expansion enabling.
      01.13.22
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Regulatory Affairs
      Ardena Expands Capacity to Satisfy Novavax COVID Vaccine Demand

      Ardena Expands Capacity to Satisfy Novavax COVID Vaccine Demand

      Site in Södertälje, Sweden will see capacity increases in purification and fractionation of GMP manufacturing.
      01.13.22
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Facilities | Industry News
      South Korean Conglomerate Invests $350M in the Center for Breakthrough Medicines

      South Korean Conglomerate Invests $350M in the Center for Breakthrough Medicines

      SK Inc. and CBM are partnering to hire 2,000 advanced therapy experts and build the largest manufacturer of cell and gene therapies in the world.
      01.13.22
    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      South Korea Approves Novavax COVID-19 Vaccine

      South Korea Approves Novavax COVID-19 Vaccine

      Nuvaxovid is the first protein-based COVID-19 vaccine granted approval in South Korea.
      01.12.22
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      San Diego Cell Therapy CDMO Acquired by Healthcare-Focused Private Equity Firm

      San Diego Cell Therapy CDMO Acquired by Healthcare-Focused Private Equity Firm

      Company also announces new name and leadership slate.
      01.11.22
    • Biologics, Proteins, Vaccines | Breaking News | Facilities | Industry News | Parenterals
      Symbiosis Expands Capabilities with BSL-2 Manufacturing Upgrade

      Symbiosis Expands Capabilities with BSL-2 Manufacturing Upgrade

      Allows the CMO to meet the needs of the expanding viral vector cell and gene therapy market.
      01.11.22
    • Biologics, Proteins, Vaccines | Breaking News | Trials & Filings
      Immune Biosolutions Lead Immunotherapy Neutralizes SARS-CoV-2 Variants

      Immune Biosolutions Lead Immunotherapy Neutralizes SARS-CoV-2 Variants

      IBIO123 is an inhaled antibody-based immunotherapy in phase 1 and 2 clinical development for the treatment of symptomatic SARS-CoV-2.
      01.10.22
    • Biologics, Proteins, Vaccines | Breaking News | Trials & Filings
      Novavax, SII File COVID Vax EUA in South Africa

      Novavax, SII File COVID Vax EUA in South Africa

      If authorized, the vaccine will be manufactured by and commercialized by SII in South Africa under the brand name Covovax.
      01.10.22
    • Bio News | Breaking News | Clinical Trials | CRO News | Industry News | R&D
      Cato SMS, Pharm-Olam Merge to Create Global Biopharma Services Company

      Cato SMS, Pharm-Olam Merge to Create Global Biopharma Services Company

      Newly combined company positioned to serve small and mid-sized biopharmaceutical companies.
      01.07.22
    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Fujifilm Cellular Dynamics and PhenoVista Biosciences Enter Drug Discovery Partnership

      Fujifilm Cellular Dynamics and PhenoVista Biosciences Enter Drug Discovery Partnership

      Enables access to services for phenotypic and high content screening imaging using iPSC-derived differentiated cells.
      01.07.22
    • Breaking News | Clinical Trials
      Pentarlandir Proves Effective Against COVID-19 Variants in Preclinical Studies

      Pentarlandir Proves Effective Against COVID-19 Variants in Preclinical Studies

      Costs for the drug are expected to be significantly lower than for Pfizer’s Paxlovid.
      01.06.22
    • Breaking News | Drug Delivery | Industry News
      Merck KGaA to Acquire Exelead for $780M

      Merck KGaA to Acquire Exelead for $780M

      Enhances the company's experience in producing lipids, one of the critical components for the formulation of mRNA therapeutics including Covid-19 vaccines.
      01.06.22
    Trending
    • Hikma Acquires Teligent Sterile Injectable Assets For $45.75M
    • Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement For COVID Oral Antivirals
    • Forge Biologics To Expand Manufacturing Facility
    • Ardena Expands Capacity To Satisfy Novavax COVID Vaccine Demand
    • South Korean Conglomerate Invests $350M In The Center For Breakthrough Medicines
    Breaking News
    • Colorcon Ventures Invests in Bio-Simulation Startup VeriSIM Life
    • Alexis Peyroles Departs OSE Immunotherapeutics as CEO
    • CARsgen Therapeutics Appoints President of U.S. Ops
    • Hikma Acquires Teligent Sterile Injectable Assets for $45.75M
    • Everest Medicines, Singapore's EDDC Enter Global Licensing Agreement for COVID Oral Antivirals
    View Breaking News >
    CURRENT ISSUE

    November/December 2021
    • Next-Gen Lab Services
    • Biopharma Manufacturing Facility Construction
    • Reviving Local Production of Antibiotic Powders
    • Understanding the Pharma Manufacturer’s Dilemma
    • Pharma Development & Manufacturing Trends
    • How to Preserve Quality in the Pharma Cold Chain
    • Fishers Innovation in Manufacturing
    • New Product Development: Single-use Technologies
    • Orphan Drug Development Trends
    • Beating the Scammers with On-Dose Authentication
      • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Krill Oil Reduces Cardiovascular Risk Factors, Study Finds
    BGG World Appoints Shaheen Majeed as CEO
    Vitamin K Status May Have Stronger Impact on COVID-19 Than Vitamin D Deficiency
    Coatings World

    Latest Breaking News From Coatings World

    Ashland Increases Prices on Coatings Products
    Paint Industry Publishes Video Guidance for Consumers
    BASF to Expand European Production of HMD and Polyamide 6.6
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Diadem's AlzoSure Predict Alzheimer's Prediction Test Gains Breakthrough Status
    FDA OKs Endo Tools' endomina System
    FDA and ECRI Partner on Medical Device Materials Safety
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Colorcon Ventures Invests in Bio-Simulation Startup VeriSIM Life
    Alexis Peyroles Departs OSE Immunotherapeutics as CEO
    CARsgen Therapeutics Appoints President of U.S. Ops
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    e.l.f. Cosmetics Unveils Cookies ‘N’ Dreams Ice Cream-Inspired Beauty Collection
    Smashbox ‘Reinvents’ the Primer Category with 4 New Launches
    Cosmoprof Worldwide Bologna Rescheduled!
    Happi

    Latest Breaking News From Happi

    New Clean Beauty, Dessert-Themed Makeup & Skin Care Line from e.l.f. Cosmetics Launches at Walmart
    Sustainable Bath & Body Products Lead 2022 Personal Care Trends
    Anti-aging Active Ingredient Regenixir by Silab Provides Rapid Regeneration to Mature Skin
    Ink World

    Latest Breaking News From Ink World

    Siegwerk Expands Ink Operations in India
    Global Ink Resins Market to Reach $3.8 Billion by 2026: MarketsandMarkets
    Epson Debuts ColorWorks C4000 Color Label Printer
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Appvion details 2030 sustainability goals
    Flexible pouch market to reach $73.5 billion by 2026
    Ettiketto Group acquires Skipnes Etikett
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Indorama Achieves ISCC Certification at Two Hygiene Sites
    Ahlstrom-Munksjö Completes Investment in Decor Paper
    GDM to Host 2022 Virtual Tour
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Surgalign's HOLO Portal AI-Driven, AR Spine Surgery Guidance System Earns FDA Nod
    FDA OK's VUZE Medical's VUZE System for Spine Surgery
    RecoveryOne Closes $33 Million Series C Financing
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Sensing Tex Announces Sensing Tex America Inc.
    Emerson Named 2022 Industrial IoT Company of the Year
    SEMI FlexTech Funds Five New R&D Projects for FHE

    Copyright © 2022 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login